Doctors trial use of hair in breast cancer test is “just wrong”
“It makes sense why patients would want to get hair transplants.”
It should be acknowledged that this is a highly problematic claim.
The trial was conducted by the US National Breast Cancer Center for the National Institute of Allergy and Infectious Diseases (NIAID), based at the National Institutes of Health (NIH), so the participants (and their families, doctors, and nurses) must have signed a nondisclosure agreement, and the trial was limited to those구미출장안마 taking chemotherapy.
So, what this study is saying is that it’s reasonable for those who take chemotherapy to have hair t바카라 게임ransplants in the first place.
Why is this important? The purpose of chemotherapy is to eliminate the cancer cells (cancerous or non-cancerous) by killing them. Hair transplants, on the other hand, is about turning a healthy looking human cell into a cancer ce공주출장안마ll, or turning one non-cancerous cell (one that makes you less sick than the cells it replaces) into a cancer cell.
That’s why there’s a legal right to receive hair transplants. But it’s the potential for side effects that’s troubling.
Because one study published by the NIAID in 2006 reported that the potential side effects of hair transplants in individuals with early stage invasive and metastatic breast cancer were similar to those of those of blood-based chemotherapy for type 2 diabetes, there seems to be reason to believe that hair transplants are of a much higher value, and that they’re more likely to cause problems than blood-based chemotherapy.
It’s also possible that some cancer patients don’t want the hair transplants and that having hair transplants may actually be their only option.
The trial has been criticized by breast cancer groups and scientists for its lack of rigour, for the possibility that the trial would reveal the risks of hair transplantation (the trial’s primary outcome measure), for the lack of clear treatment and management strategies for breast cancer, and for a few “pink slips” in the trial design, all of which we can all point to and point fingers at.
So the results of this study don’t have enough solid scientific data to make much of a dent in the breast cancer industry’s belief that breast cancer is completely or almost completely cured, and that this study is a complete waste of money.